| Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults (NCT01227330) | University of Missouri-Columbia | 2010-10-01 |
| rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors (NCT01071941) | Kenneth K. Tanabe, MD | 2010-10-01 |
| MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer (NCT02578602) | University of Southern California | 2010-10-01 |
| A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer (NCT01188707) | Herlev Hospital | 2010-10-01 |
| A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers (NCT01209195) | Merrimack Pharmaceuticals | 2010-10-01 |
| A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies (NCT01204073) | Millennium Pharmaceuticals, Inc. | 2010-10-01 |
| A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis (NCT01385644) | The Prince Charles Hospital | 2010-10-01 |
| Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors (NCT01239134) | Leap Therapeutics, Inc. | 2010-10-01 |
| Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome (NCT01595828) | Kowa Research Europe | 2010-10-01 |
| Vitamin E for Extremely Preterm Infants (NCT01193270) | NICHD Neonatal Research Network | 2010-10-01 |
| A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia (NCT01274104) | Avera McKennan Hospital & University Health Center | 2010-10-01 |
| Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate (NCT02284880) | Bial - Portela C S.A. | 2010-10-01 |
| Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury (NCT00810940) | Abela Pharmaceuticals, Inc. | 2010-10-01 |
| Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT01215786) | Allergan | 2010-10-01 |
| Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) (NCT01254539) | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 2010-10-01 |
| Hearing Impairment, Cognitive Therapy and Coping (NCT01206829) | Oslo University Hospital | 2010-10-01 |
| Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept (NCT01221636) | Bristol-Myers Squibb | 2010-10-01 |
| Therapeutic Effects of Neurofeedback in Anorexia Nervosa (NCT01390493) | Medical University of Graz | 2010-10-01 |
| Susceptibility of Human Volunteers With Different Histo-Blood With Different Histo-Blood Group Antigens to Norovirus (NCT01322503) | Children's Hospital Medical Center, Cincinnati | 2010-10-01 |
| Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors (NCT01188499) | TetraLogic Pharmaceuticals | 2010-10-01 |
| Endoscopic Treatment of Intestinal Fistulas and Perforations (NCT01303653) | The Oregon Clinic | 2010-10-01 |
| A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions (NCT01710995) | Norgine | 2010-10-01 |
| Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects (NCT01250366) | Bristol-Myers Squibb | 2010-10-01 |
| Comparison of Flu Vaccine Doses in Children (NCT01164553) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| OCT Evaluation of Healing of COMBO Stent (NCT01274234) | Prof. Stephen Lee | 2010-10-01 |
| A Research Trial of Aralast in New Onset Diabetes (RETAIN) (NCT01183468) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes (NCT01319331) | University of Colorado, Denver | 2010-10-01 |
| Hydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD Patients (NCT01402297) | Medical University of Lodz | 2010-10-01 |
| A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941 (NCT01674777) | Astellas Pharma Inc | 2010-10-01 |
| Study of Digestive Tolerance of Orange Juice With Fibers (NCT01282983) | University of Sao Paulo | 2010-10-01 |
| Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma (NCT01147393) | Weill Medical College of Cornell University | 2010-10-01 |
| Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer (NCT01229618) | University of California, San Francisco | 2010-10-01 |
| Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine (NCT01320176) | Institut Pasteur | 2010-10-01 |
| Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) (NCT01220518) | Celltrion | 2010-10-01 |
| Trimodality Management of T1b Esophageal Cancers (NCT01217060) | M.D. Anderson Cancer Center | 2010-10-01 |
| A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers (NCT01181700) | Pfizer | 2010-10-01 |
| RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer (NCT01149356) | National Cancer Institute (NCI) | 2010-10-01 |
| A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors (NCT01195376) | Novartis Pharmaceuticals | 2010-10-01 |
| Paramedic Initiated Lisinopril For Acute Stroke Treatment (NCT01066572) | Newcastle-upon-Tyne Hospitals NHS Trust | 2010-10-01 |
| A Study of LY2216684 in Participants With Impaired Hepatic Function (NCT01241435) | Eli Lilly and Company | 2010-10-01 |
| Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study (NCT01255527) | Yonsei University | 2010-10-01 |
| Safety and Tolerability of AFFITOPE AD03 (NCT01309763) | Affiris AG | 2010-10-01 |
| Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Relapsed/Refractory Leukemias (NCT01239108) | Astex Pharmaceuticals, Inc. | 2010-10-01 |
| Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age (NCT01193920) | Novartis Vaccines | 2010-10-01 |
| Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects (NCT01211860) | Essentialis, Inc. | 2010-10-01 |
| A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis. (NCT01164384) | University of Zurich | 2010-10-01 |
| Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics (NCT01357876) | GlaxoSmithKline | 2010-10-01 |
| Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) (NCT01212380) | Ohio State University Comprehensive Cancer Center | 2010-10-01 |
| Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule (NCT01242618) | University Hospital, Basel, Switzerland | 2010-10-01 |
| Rectal Safety and Acceptability Study of Tenofovir 1% Gel (NCT01232803) | CONRAD | 2010-10-01 |
| CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM (NCT01109095) | Baylor College of Medicine | 2010-10-01 |
| A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma (NCT01209130) | Genentech, Inc. | 2010-10-01 |
| Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance (NCT01237899) | Eli Lilly and Company | 2010-10-01 |
| Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients (NCT01120912) | Oshadi Drug Administration | 2010-10-01 |
| Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition (NCT01923558) | Dr. Reddy's Laboratories Limited | 2010-10-01 |
| Safety Study of BIIB033 in Subjects With Multiple Sclerosis (NCT01244139) | Biogen | 2010-10-01 |
| Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) (NCT01252797) | University of Alabama at Birmingham | 2010-10-01 |
| Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema (NCT01306513) | Leiden University Medical Center | 2010-10-01 |
| A Pilot Randomized Controlled Trial of Repeated Hands-and-Knees Positioning During Labour (NCT01720004) | University of Toronto | 2010-10-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule (NCT01202435) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-10-01 |
| Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates (NCT02050971) | Pomeranian Medical University Szczecin | 2010-10-01 |
| Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate (NCT01150526) | Metabolic Technologies Inc. | 2010-10-01 |
| Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041) (NCT01223339) | Merck Sharp & Dohme LLC | 2010-10-01 |
| Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. (NCT01066468) | Novartis Pharmaceuticals | 2010-10-01 |
| A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1 (NCT01247194) | Presidio Pharmaceuticals, Inc. | 2010-10-01 |
| Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers (NCT01216384) | Boehringer Ingelheim | 2010-10-01 |
| Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin (NCT01681680) | University of California, San Francisco | 2010-10-01 |
| A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors (NCT01210846) | AVEO Pharmaceuticals, Inc. | 2010-10-01 |
| Paracétamol PMB by Sublingual et Buccal Routes (NCT01206985) | University Hospital, Clermont-Ferrand | 2010-10-01 |
| Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions (NCT01224587) | AstraZeneca | 2010-10-01 |
| Safety and Performance of the CAVU Medical, Inc. Attune Tubing Study (NCT01422941) | Cavu Medical, Inc. | 2010-10-01 |
| Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics (NCT01215214) | Seoul National University Hospital | 2010-10-01 |
| Effects of Insomnia on Simulated Driving (MK-0000-183-00) (NCT01209728) | Merck Sharp & Dohme LLC | 2010-10-01 |
| Safety Study of High Doses of Zinc in ALS Patients (NCT01259050) | Phoenix Neurological Associates, LTD | 2010-10-01 |
| Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers (NCT01889849) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2010-10-01 |
| A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects (NCT01279915) | Astellas Pharma Inc | 2010-10-01 |
| Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab (NCT01213238) | M.D. Anderson Cancer Center | 2010-09-30 |
| A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A (NCT01318980) | GlaxoSmithKline | 2010-09-30 |
| Effect of Teduglutide on Gastric Emptying in Healthy Subjects (NCT01209351) | Shire | 2010-09-28 |
| Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma (NCT01211262) | Immunocore Ltd | 2010-09-28 |
| Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers (NCT01136928) | Johns Hopkins University | 2010-09-28 |
| Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension (NCT01157364) | Allergan | 2010-09-23 |
| Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors (NCT01407562) | Rutgers, The State University of New Jersey | 2010-09-17 |
| First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients (NCT01191372) | Baxalta now part of Shire | 2010-09-15 |
| Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel (NCT01192165) | GlaxoSmithKline | 2010-09-14 |
| Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy (NCT01537549) | Weill Medical College of Cornell University | 2010-09-14 |
| Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors (NCT01206465) | University of Nebraska | 2010-09-14 |
| A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects. (NCT01195974) | ViiV Healthcare | 2010-09-14 |
| Phase I Study of ETEC Vaccine (NCT01147445) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-13 |
| A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (NCT01254071) | GlaxoSmithKline | 2010-09-10 |
| Study of Everolimus (RAD001) in Combination With Lenalidomide (NCT01218555) | Emory University | 2010-09-09 |
| Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer (NCT01208051) | National Cancer Institute (NCI) | 2010-09-09 |
| Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects (NCT01442831) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2010-09-09 |
| First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor (NCT01156870) | Sanofi | 2010-09-08 |
| Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal Carcinoma (NCT01380600) | Jennerex Biotherapeutics | 2010-09-08 |
| Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00568880) | Abramson Cancer Center at Penn Medicine | 2010-09-08 |
| Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism (NCT01134562) | KAI Pharmaceuticals | 2010-09-07 |
| Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance (NCT01197170) | M.D. Anderson Cancer Center | 2010-09-07 |
| Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma (NCT01165333) | Centre Oscar Lambret | 2010-09-06 |
| Bivalent Norovirus Vaccine Study (NCT01168401) | Takeda | 2010-09-03 |